Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
CONCLUSION: The intratumor injection of rAd-p53 into patients with cervical cancer is safe and effective, showing a new way in the gene therapy of cervical cancer. Both ASPP and P-gp may be potential biomarkers in the treatment of cervical cancer.
PMID: 31424649 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Gene Therapy | Genetics | Hysterectomy | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Statistics